Fanconi anaemia (FA) is an autosomal recessive disease featuring diver
se clinical symptoms in addition to chromosomal instability and hypers
ensitivity to crosslinking agents. The much increased risk of FA patie
nts developing leukaemia and squamous cell carcinomas makes FA an impo
rtant model disease for cancer predisposition. Studies documenting the
characteristics of FA cells and their response to environmental toxin
s have failed thus far to disclose the basic cellular process that is
primarily disturbed in FA cells. Complementation analysis suggests tha
t mutations in at least four different genes can cause FA (complementa
tion groups FA-A to FA-D). The cDNA for FA-C has been cloned and found
to encode a novel protein that localises to the cytoplasmic compartme
nt of cells. Even though the protein's function is still unknown at pr
esent, research has now reached the point from where rapid progress to
a detailed understanding of this syndrome may be foreseen.